Although the percentage of patients with advanced-stage disease was higher during the pandemic (64% vs 53.8%), this difference did not reach statistical significance ( P = 0.384).
← all excerpts
Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic.
1
0.3840
0.3840